| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,472 |
28,606 |
$1.99M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,934 |
13,087 |
$596K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,561 |
4,926 |
$489K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,524 |
9,352 |
$374K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24,191 |
10,695 |
$237K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,892 |
2,644 |
$173K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,260 |
7,735 |
$163K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,277 |
15,276 |
$138K |
| 99215 |
Prolong outpt/office vis |
1,506 |
1,238 |
$106K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,085 |
546 |
$24K |
| 87807 |
|
1,685 |
1,531 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
134 |
126 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
103 |
99 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,094 |
3,499 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
103 |
92 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,372 |
5,421 |
$6K |
| 81002 |
|
3,785 |
3,248 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
4,145 |
3,477 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,682 |
1,444 |
$3K |
| 81025 |
|
639 |
561 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
234 |
181 |
$2K |
| 69210 |
|
70 |
61 |
$2K |
| 3008F |
|
297 |
229 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
25 |
23 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
211 |
192 |
$2K |
| 3074F |
|
173 |
143 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40 |
38 |
$1K |
| 3078F |
|
96 |
89 |
$710.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
28 |
24 |
$394.98 |
| 3079F |
|
61 |
42 |
$300.00 |
| 80305 |
|
13 |
13 |
$47.99 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
233 |
180 |
$23.76 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
14 |
12 |
$23.66 |
| 3077F |
|
18 |
13 |
$20.00 |
| 3061F |
|
16 |
12 |
$0.00 |
| 99072 |
|
255 |
233 |
$0.00 |